SCHEMBL21142998

SCHEMBL21142998

CCCCC(CC)CC(CC)CN(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
TDP1 Q9NUW8 2/20 0.46
CYP3A4 P08684 5/20 0.45
TSHR P16473 4/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
CA2 P00918 2/20 0.38
ATM Q13315 1/20 0.35
LMNA P02545 2/20 0.33
HSD17B10 Q99714 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CHRM1 P11229 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL29202866 0.89 CA2 (0.43) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL758600 0.89 ALDH1A1 (0.56) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL21166541 0.87 ALDH1A1 (0.46) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
Hydrochloric Acid SCHEMBL2246591 0.86 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL8754719 0.84 ALDH1A1 (0.44) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL21142987 0.83 ALDH1A1 (0.43) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL20623369 0.83 ALDH1A1 (0.39) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4281881 0.83 ALDH1A1 (0.62) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL21629308 0.82 ALDH1A1 (0.42) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL16594856 0.81 ALDH1A1 (0.59) ALDH1A1TDP1CYP3A4TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111601786-A Branched trialkylamine precursors, intermediates, products made therefrom, and methods of making 伊士曼化工公司 2020-08-28 CN claimed
CN-111601786-B Branched trialkylamine precursors, intermediates, products made therefrom and methods of making 伊士曼化工公司 2024-03-12 CN disclosed
US-10961180-B2 Branched trialkyl amine oxides EASTMAN CHEMICAL COMPANY (US) 2021-03-30 US disclosed
US-10961180-B2 Branched trialkyl amine oxides EASTMAN CHEMICAL COMPANY (US) 2021-03-30 US disclosed
CN-111601786-A Branched trialkylamine precursors, intermediates, products made therefrom, and methods of making 伊士曼化工公司 2020-08-28 CN disclosed
US-10640452-B2 Branched trialkyl quaternary ammonium compounds EASTMAN CHEMICAL COMPANY (US) 2020-05-05 US disclosed
US-10640452-B2 Branched trialkyl quaternary ammonium compounds EASTMAN CHEMICAL COMPANY (US) 2020-05-05 US disclosed
US-20190218170-A1 BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE EASTMAN CHEMICAL COMPANY (US) 2019-07-18 US disclosed
US-20190218170-A1 BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE EASTMAN CHEMICAL COMPANY (US) 2019-07-18 US disclosed
US-20190218169-A1 BRANCHED TRIALKYL AMINE OXIDES EASTMAN CHEMICAL COMPANY (US) 2019-07-18 US disclosed
US-20190218169-A1 BRANCHED TRIALKYL AMINE OXIDES EASTMAN CHEMICAL COMPANY (US) 2019-07-18 US disclosed
US-20190218171-A1 BRANCHED TRIALKYL QUATERNARY AMMONIUM COMPOUNDS EASTMAN CHEMICAL COMPANY (US) 2019-07-18 US disclosed
US-20190218171-A1 BRANCHED TRIALKYL QUATERNARY AMMONIUM COMPOUNDS EASTMAN CHEMICAL COMPANY (US) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190218169-A1 BRANCHED TRIALKYL AMINE OXIDES C5, OR10J3, ALKBH5 ALDH1A1 409/4885TDP1 3676/4885CYP3A4 2355/4885
US-20190218171-A1 BRANCHED TRIALKYL QUATERNARY AMMONIUM COMPOUNDS ELOVL3, ELOVL5, ALK ALDH1A1 1343/4885TDP1 4325/4885CYP3A4 1135/4885
US-10640452-B2 Branched trialkyl quaternary ammonium compounds BCKDK, PFKL, GLUL ALDH1A1 4533/4885TDP1 4002/4885CYP3A4 2540/4885
US-20190218170-A1 BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE ACADM, ALK, FASN ALDH1A1 1105/4885TDP1 4318/4885CYP3A4 249/4885
US-10961180-B2 Branched trialkyl amine oxides C5, OR10J3, ALKBH5 ALDH1A1 409/4885TDP1 3676/4885CYP3A4 2355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.